GeneDx Non Current Assets Total from 2010 to 2025

WGSWW Stock   0.25  0.01  3.85%   
GeneDx Holdings Non Current Assets Total yearly trend continues to be fairly stable with very little volatility. Non Current Assets Total will likely drop to about 206.6 M in 2025. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2010-12-31
Previous Quarter
221.4 M
Current Value
206.6 M
Quarterly Volatility
79.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 31.3 M or Selling General Administrative of 142 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0 or PTB Ratio of 8.85. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
  
Check out the analysis of GeneDx Holdings Correlation against competitors.

Latest GeneDx Holdings' Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of GeneDx Holdings Corp over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. GeneDx Holdings' Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
70.278291221206295%5%-24%-7%100%
       Timeline  

GeneDx Non Current Assets Total Regression Statistics

Arithmetic Mean120,068,938
Geometric Mean102,952,655
Coefficient Of Variation66.10
Mean Deviation64,675,531
Median77,534,000
Standard Deviation79,368,091
Sample Variance6299.3T
Range220.8M
R-Value0.70
Mean Square Error3457.6T
R-Squared0.49
Significance0
Slope11,642,043
Total Sum of Squares94489.4T

GeneDx Non Current Assets Total History

2025206.6 M
2024221.4 M
2023291.3 M
2022278.3 M
202170.5 M

About GeneDx Holdings Financial Statements

GeneDx Holdings investors use historical fundamental indicators, such as GeneDx Holdings' Non Current Assets Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeneDx Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Assets Total221.4 M206.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.
News Freq…Investor S…